Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention

作者: Maher Rabah , Denise Mason , David W.M Muller , Randal Hundley , Aaron D Kugelmass

DOI: 10.1016/S0735-1097(99)00195-3

关键词: PercutaneousHeparinRandomized controlled trialUnstable anginaClinical endpointIschemiaMedicineSurgeryAnticoagulantVascular disease

摘要: OBJECTIVES The purpose of this study was to determine the incidence bleeding, vascular, and ischemic complications using three different heparin regimens after successful intervention. BACKGROUND ideal dose duration infusion coronary intervention is unknown. METHODS Patients were randomized one strategies intervention: Group 1 (n = 157 patients) received prolonged (12 24 h) followed by sheath removal; 2 120 underwent early removal sheaths, reinstitution for 12 18 h; 3 137 did not receive any further with removal. primary end point combined in-hospital bleeding vascular events. Secondary points included events, length stay, cost one-month outcome. RESULTS After intervention, 414 patients randomized. Unstable angina or postinfarction present in 83% before events 21% 1, 14% 8% (p 0.01). overall 2.2%; there no differences between groups. Length hospital stay shorter 0.033) adjusted lower < 0.001) 3. At 30 days, delayed cardiac similar all CONCLUSIONS Heparin associated more minor injury, increased cost. In-hospital rarely occur irrespective use. Routine postprocedure recommended, even who unstable syndromes.

参考文章(50)
Amilcar Avendan̄o, James J. Ferguson, Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty Journal of the American College of Cardiology. ,vol. 23, pp. 907- 910 ,(1994) , 10.1016/0735-1097(94)90636-X
G Dorros, M J Cowley, J Simpson, L G Bentivoglio, P C Block, M Bourassa, K Detre, A J Gosselin, A R Grüntzig, S F Kelsey, K M Kent, M B Mock, S M Mullin, R K Myler, E R Passamani, S H Stertzer, D O Williams, Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation. ,vol. 67, pp. 723- 730 ,(1983) , 10.1161/01.CIR.67.4.723
David J. Moliterno, Robert M. Califf, Frank V. Aguirre, Keaven Anderson, Kristina N. Sigmon, Harlan F. Weisman, Eric J. Topol, The EPIC Study Investigators, Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial) American Journal of Cardiology. ,vol. 75, pp. 559- 562 ,(1995) , 10.1016/S0002-9149(99)80616-X
Robert A. Raschke, The Weight-based Heparin Dosing Nomogram Compared with a Standard Care Nomogram Annals of Internal Medicine. ,vol. 119, pp. 874- 881 ,(1993) , 10.7326/0003-4819-119-9-199311010-00002
Steven W. Oweida, Gary S. Roubin, Robert B. Smith, Atef A. Salam, Postcatheterization vascular complications associated with percutaneous transluminal coronary angioplasty. Journal of Vascular Surgery. ,vol. 12, pp. 310- 315 ,(1990) , 10.1016/0741-5214(90)90153-2
Edoardo Camenzind, Marianne Grossholz, Philip Urban, Pierre-André Dorsaz, Dominique Didier, Bernhard Meier, Collagen application versus manual compression: A prospective randomized trial for arterial puncture site closure after coronary angioplasty Journal of the American College of Cardiology. ,vol. 24, pp. 655- 662 ,(1994) , 10.1016/0735-1097(94)90011-6
E J Topol, R Bonan, D Jewitt, U Sigwart, V V Kakkar, M Rothman, D de Bono, J Ferguson, J T Willerson, J Strony, Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty. Circulation. ,vol. 87, pp. 1622- 1629 ,(1993) , 10.1161/01.CIR.87.5.1622
David W.M. Muller, Kenath J. Shamir, Stephen G. Ellis, Eric J. Topol, Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. American Journal of Cardiology. ,vol. 69, pp. 63- 68 ,(1992) , 10.1016/0002-9149(92)90677-Q
Laurence A. Harker, Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty The American Journal of Cardiology. ,vol. 60, pp. 20- 28 ,(1987) , 10.1016/0002-9149(87)90479-6
Gene R. Pesola, Audrey Johnson, David A. Pesola, Percutaneous transluminal coronary angioplasty: comparison of arterial vs. venous activated clotting time. Catheterization and Cardiovascular Diagnosis. ,vol. 37, pp. 140- 144 ,(1996) , 10.1002/(SICI)1097-0304(199602)37:2<140::AID-CCD7>3.0.CO;2-D